Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “California”

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsRecruiting
NCT03866382Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Bladder Adenocarcinoma · Bladder Clear Cell Adenocarcinoma · Bladder Mixed Adenocarcinoma · Bladder Neuroendocrine Carcinoma
United States, Puerto Rico
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular LymphomaRecruiting
NCT06337318Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Classic Follicular Lymphoma · Follicular Lymphoma With Unusual Cytological Features
United States
A Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Trial ParticipantsCompleted
NCT07717918Phase 1Updated Sep 10, 2026
Sponsor: Bausch & Lomb Incorporated
Healthy
United States
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyRecruiting
NCT05136196Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Clinical Stage III Cutaneous Melanoma AJCC v8 · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage IV Cutaneous Melanoma AJCC v8 · Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
United States
Prediction of REsponse to Depression Interventions (Accelerated rTMS) Using Clinical and TD-fNIRS MeasurementsTerminated
NCT07294924N/AUpdated Sep 10, 2026
Sponsor: Kernel
Major Depressive Disorder (MDD) · fNIRS
United States
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal CancerActive Not Recruiting
NCT03233711Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Anal Basaloid Carcinoma · Anal Canal Cloacogenic Carcinoma · Anal Margin Squamous Cell Carcinoma · Stage IIB Anal Cancer AJCC v8
United States, Canada
Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular MelanomaCompleted
NCT02678572Phase 3Updated Sep 10, 2026
Sponsor: Delcath Systems Inc.
Ocular Melanoma · Uveal Melanoma
United States, Austria, Belgium, France, Germany +4 more
A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.Recruiting
NCT07356453Phase 1Updated Sep 10, 2026
Sponsor: FoRx Therapeutics AG
Advanced Solid Tumors
United States
Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal DystrophyNot Yet Recruiting
NCT07750678Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: GenEditBio Limited
Hereditary Corneal Dystrophy · Corneal Abnormality · Corneal Dystrophies · Corneal Dystrophies, Hereditary
United States, China
Meditative Neurofeedback for DepressionRecruiting
NCT06675240NAUpdated Sep 10, 2026
Sponsor: University of California, San Diego
Depression - Major Depressive Disorder · Depression Disorders
United States
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade GliomaRecruiting
NCT04166409Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Low Grade Astrocytoma · Low Grade Glioma · Metastatic Low Grade Astrocytoma · Metastatic Low Grade Glioma
United States, Canada, Puerto Rico
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1Completed
NCT05507203Phase 3Updated Sep 10, 2026
Sponsor: Abivax S.A.
Ulcerative Colitis
United States, Argentina, Australia, Austria, Belgium +19 more
Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)Recruiting
NCT07453888Phase 3Updated Sep 10, 2026
Sponsor: Dompé Farmaceutici S.p.A
Non-Arteritic Anterior Ischemic Optic Neuropathy
United States, Australia, United Kingdom
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative NeoplasmsRecruiting
NCT06150157Phase 1Updated Sep 10, 2026
Sponsor: Janssen Research & Development, LLC
Neoplasms
United States, Canada, China, France, Germany +5 more
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815Active Not Recruiting
NCT05557045Phase 1Updated Sep 10, 2026
Sponsor: Jazz Pharmaceuticals
Advanced Cancer · Metastatic Cancer · Solid Tumor · Melanoma
United States
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell LymphomaRecruiting
NCT06649812Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements · Recurrent Diffuse Large B-Cell Lymphoma · Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type · Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
United States
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor FluctuationsRecruiting
NCT07432958Phase 2Updated Sep 10, 2026
Sponsor: Appello Pharmaceuticals, Inc.
Parkinson Disease
United States
A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder CancerCompleted
NCT03661320Phase 3Updated Sep 10, 2026
Sponsor: Bristol-Myers Squibb
Urinary Bladder Neoplasms · Muscle-Invasive Bladder Cancer
United States, Argentina, Australia, Austria, Belgium +23 more
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use DisorderRecruiting
NCT04375033Phase 4Updated Sep 10, 2026
Sponsor: VA Office of Research and Development
Opioid Use Disorder
United States
Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the BonesActive Not Recruiting
NCT04090398Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Anatomic Stage IV Breast Cancer AJCC v8 · Metastatic HER2-Negative Breast Carcinoma · Metastatic Malignant Neoplasm in the Bone
United States
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerRecruiting
NCT04181060Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Lung Non-Squamous Non-Small Cell Carcinoma · Metastatic Lung Non-Squamous Non-Small Cell Carcinoma · Recurrent Lung Non-Squamous Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8
United States
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)Recruiting
NCT06124157Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
B Acute Lymphoblastic Leukemia
United States, Australia, Canada, Puerto Rico
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisRecruiting
NCT07299019Phase 3Updated Sep 10, 2026
Sponsor: Zenas BioPharma (USA), LLC
Secondary Progressive Multiple Sclerosis
United States, Croatia, Czechia, Estonia, Italy +4 more
An Open-Label Phase II Feasibility Study for the Use of Ublituximab in Adults With Down Syndrome Regression DisorderNot Yet Recruiting
NCT07812181Phase 2Updated Sep 10, 2026
Sponsor: Jonathan Santoro
Down Syndrome Regression Disorder (DSRD) · Down Syndrome (Trisomy 21) · Neuroinflammatory / Neuropsychiatric Disorder
United States
Development and Testing of a Sports Intervention to Promote Physical Activity in Rural GirlsEnrolling By Invitation
NCT06229457NAUpdated Sep 10, 2026
Sponsor: San Diego State University
Healthy
United States

Previous page Next page